{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T08:58:26Z","timestamp":1754557106678},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>There has been a considerable amount of debate among the research community whether cannabis use may cause schizophrenia and whether cannabis use of patients with schizophrenia is associated with earlier and more frequent relapses. Considering that studies exploring patients' view on controversial topics have contributed to our understanding of important clinical issues, it is surprising how little these views have been explored to add to our understanding of the link between cannabis and psychosis. The present study was designed to elucidate whether patients with schizophrenia who use cannabis believe that its use has caused their schizophrenia and to explore these patients other beliefs and perceptions about the effects of the drug.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We recruited ten consecutive patients fulfilling criteria for paranoid schizophrenia and for a harmful use of\/dependence from cannabis (ICD-10 F20.0 + F12.1 or F12.2) from the in- and outpatient clinic of the Psychiatric University Hospital Zurich. They were interviewed using qualitative methodology. Furthermore, information on amount, frequency, and effects of use was obtained. A grounded theory approach to data analysis was taken to evaluate findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>None of the patients described a causal link between the use of cannabis and their schizophrenia. Disease models included upbringing under difficult circumstances (5) or use of substances other than cannabis (e. g. hallucinogens, 3). Two patients gave other reasons. Four patients considered cannabis a therapeutic aid and reported that positive effects (reduction of anxiety and tension) prevailed over its possible disadvantages (exacerbation of positive symptoms).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with schizophrenia did not establish a causal link between schizophrenia and the use of cannabis. We suggest that clinicians consider our findings in their work with patients suffering from these co-occurring disorders. Withholding treatment or excluding patients from certain treatment settings like day-care facilities or in patient care because of their use of cannabis, may cause additional harm to this already heavily burdened patient group.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1477-7517-7-22","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T18:15:01Z","timestamp":1285697701000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia"],"prefix":"10.1186","volume":"7","author":[{"given":"Anna","family":"Buadze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Stohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Liebrenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,28]]},"reference":[{"key":"190_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0140-6736(06)68012-4","volume":"367","author":"W Hall","year":"2006","unstructured":"Hall W: Is cannabis use psychotogenic?. Lancet. 2006, 367: 193-195. 10.1016\/S0140-6736(06)68012-4.","journal-title":"Lancet"},{"key":"190_CR2","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0140-6736(06)68468-7","volume":"367","author":"J Macleod","year":"2006","unstructured":"Macleod J, Davey Smith G, Hickman M: Does cannabis use cause schizophrenia?. Lancet. 2006, 367: 1055-10.1016\/S0140-6736(06)68468-7.","journal-title":"Lancet"},{"key":"190_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1192\/bjp.bp.107.046375","volume":"193","author":"S Zammit","year":"2008","unstructured":"Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G: Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry. 2008, 193: 357-363. 10.1192\/bjp.bp.107.046375.","journal-title":"Br J Psychiatry"},{"key":"190_CR4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","volume":"2","author":"S Andreasson","year":"1987","unstructured":"Andreasson S, Allebeck P, Engstrom A, Rydberg U: Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987, 2: 1483-1486. 10.1016\/S0140-6736(87)92620-1.","journal-title":"Lancet"},{"key":"190_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(04)16200-4","volume":"363","author":"J Macleod","year":"2004","unstructured":"Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, Oppenkowski T, Stokes-Lampard H, Davey Smith G: Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet. 2004, 363: 1579-1588. 10.1016\/S0140-6736(04)16200-4.","journal-title":"Lancet"},{"key":"190_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"TH Moore","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G: Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007, 370: 319-328. 10.1016\/S0140-6736(07)61162-3.","journal-title":"Lancet"},{"key":"190_CR7","doi-asserted-by":"publisher","first-page":"a288","DOI":"10.1136\/bmj.a288","volume":"337","author":"A Kuper","year":"2008","unstructured":"Kuper A, Reeves S, Levinson W: An introduction to reading and appraising qualitative research. BMJ (Clinical research ed. 2008, 337: a288-10.1136\/bmj.a288.","journal-title":"BMJ (Clinical research ed"},{"key":"190_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1464-5491.2008.02400.x","volume":"25","author":"J Lawton","year":"2008","unstructured":"Lawton J, Peel E, Parry O, Douglas M: Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study. Diabet Med. 2008, 25: 491-495. 10.1111\/j.1464-5491.2008.02400.x.","journal-title":"Diabet Med"},{"key":"190_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1136\/bmj.325.7369.873","volume":"325","author":"J Benson","year":"2002","unstructured":"Benson J, Britten N: Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ (Clinical research ed. 2002, 325: 873-10.1136\/bmj.325.7369.873.","journal-title":"BMJ (Clinical research ed"},{"key":"190_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/10966210360510082","volume":"6","author":"SJ Farber","year":"2003","unstructured":"Farber SJ, Egnew TR, Herman-Bertsch JL, Taylor TR, Guldin GE: Issues in end-of-life care: patient, caregiver, and clinician perceptions. Journal of palliative medicine. 2003, 6: 19-31. 10.1089\/10966210360510082.","journal-title":"Journal of palliative medicine"},{"key":"190_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.148.2.224","volume":"148","author":"L Dixon","year":"1991","unstructured":"Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ: Drug abuse in schizophrenic patients: clinical correlates and reasons for use. The American journal of psychiatry. 1991, 148: 224-230.","journal-title":"The American journal of psychiatry"},{"key":"190_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1080\/00048670802512016","volume":"42","author":"M Schaub","year":"2008","unstructured":"Schaub M, Fanghaenel K, Stohler R: Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. The Australian and New Zealand journal of psychiatry. 2008, 42: 1060-1065. 10.1080\/00048670802512016.","journal-title":"The Australian and New Zealand journal of psychiatry"},{"key":"190_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1080\/j.1440-1614.2006.01840.x","volume":"40","author":"D Schofield","year":"2006","unstructured":"Schofield D, Tennant C, Nash L, Degenhardt L, Cornish A, Hobbs C, Brennan G: Reasons for cannabis use in psychosis. The Australian and New Zealand journal of psychiatry. 2006, 40: 570-574.","journal-title":"The Australian and New Zealand journal of psychiatry"},{"key":"190_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1600-0447.1997.tb09925.x","volume":"96","author":"J Addington","year":"1997","unstructured":"Addington J, Duchak V: Reasons for substance use in schizophrenia. Acta Psychiatr Scand. 1997, 96: 329-333. 10.1111\/j.1600-0447.1997.tb09925.x.","journal-title":"Acta Psychiatr Scand"},{"key":"190_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/10550490490435795","volume":"13","author":"S Goswami","year":"2004","unstructured":"Goswami S, Mattoo SK, Basu D, Singh G: Substance-abusing schizophrenics: do they self-medicate?. Am J Addict. 2004, 13: 139-150. 10.1080\/10550490490435795.","journal-title":"Am J Addict"},{"key":"190_CR16","first-page":"356","volume":"39","author":"H Faller","year":"1993","unstructured":"Faller H: [Subjective illness theories: determinants or epiphenomena of coping with illness? A comparison of methods in patients with bronchial cancer]. Zeitschrift fur Psychosomatische Medizin und Psychoanalyse. 1993, 39: 356-374.","journal-title":"Zeitschrift fur Psychosomatische Medizin und Psychoanalyse"},{"key":"190_CR17","volume-title":"Newbury Park, CA:Sage","author":"MQ Patton","year":"1990","unstructured":"Patton MQ: Qualitative evaluation and research methods. Newbury Park, CA:Sage. 1990"},{"key":"190_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/bmj.311.6996.42","volume":"311","author":"C Pope","year":"1995","unstructured":"Pope C, Mays N: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ (Clinical research ed. 1995, 311: 42-45.","journal-title":"BMJ (Clinical research ed"},{"key":"190_CR19","volume-title":"Grounded Theory: Strategien qualitativer Forschung (Grounded theory: Strategies for qualitative research)","author":"BJ Glaser","year":"2008","unstructured":"Glaser BJ, Strauss AL: Grounded Theory: Strategien qualitativer Forschung (Grounded theory: Strategies for qualitative research). 2008, Bern: Huber, 2","edition":"2"},{"key":"190_CR20","volume-title":"Heidelberg: Asanger","author":"H Faller","year":"1994","unstructured":"Faller H, Frommer J: Qualitative Psychotherapieforschung. Grundlagen und Methoden. Heidelberg: Asanger. 1994"},{"key":"190_CR21","volume-title":"Chicago, IL: Aldine De Gruyther","author":"BJ Glaser","year":"1967","unstructured":"Glaser BJ, Strauss AL: The discovery of grounded theory: Strategies for Qualitative Research. Chicago, IL: Aldine De Gruyther. 1967"},{"key":"190_CR22","first-page":"468","volume-title":"Qualitative Forschung Ein Handbuch (Qualitative Research: A Handbook)","author":"P Mayring","year":"2005","unstructured":"Mayring P: Qualitative Inhaltsanalyse (Qualitative Content Analysis). Qualitative Forschung Ein Handbuch (Qualitative Research: A Handbook). Edited by: Flick U, Kardorff E, Steinke I. 2005, Reinbeck bei Hamburg: Rowohlts Taschenbuch Verlag, 468-475. 4","edition":"4"},{"key":"190_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF00381080","volume":"238","author":"MC Angermeyer","year":"1988","unstructured":"Angermeyer MC, Klusmann D: The causes of functional psychoses as seen by patients and their relatives. I. The patients' point of view. European archives of psychiatry and neurological sciences. 1988, 238: 47-54. 10.1007\/BF00381080.","journal-title":"European archives of psychiatry and neurological sciences"},{"key":"190_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-2001-15995","volume":"51","author":"A Holzinger","year":"2001","unstructured":"Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC: [Causal beliefs of schizophrenic patients]. Psychotherapie, Psychosomatik, medizinische Psychologie. 2001, 51: 328-333. 10.1055\/s-2001-15995.","journal-title":"Psychotherapie, Psychosomatik, medizinische Psychologie"},{"key":"190_CR25","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/schbul\/sbn117","volume":"34","author":"J van Os","year":"2008","unstructured":"van Os J, Rutten BP, Poulton R: Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophrenia bulletin. 2008, 34: 1066-1082. 10.1093\/schbul\/sbn117.","journal-title":"Schizophrenia bulletin"},{"key":"190_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000236906","volume":"42","author":"N Dekker","year":"2009","unstructured":"Dekker N, Linszen DH, De Haan L: Reasons for Cannabis Use and Effects of Cannabis Use as Reported by Patients with Psychotic Disorders. Psychopathology. 2009, 42: 350-360. 10.1159\/000236906.","journal-title":"Psychopathology"},{"key":"190_CR27","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.1360-0443.2008.02230.x","volume":"103","author":"J McLaren","year":"2008","unstructured":"McLaren J, Swift W, Dillon P, Allsop S: Cannabis potency and contamination: a review of the literature. Addiction (Abingdon, England). 2008, 103: 1100-1109. 10.1111\/j.1360-0443.2008.02230.x.","journal-title":"Addiction (Abingdon, England)"},{"key":"190_CR28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/10826087509028358","volume":"10","author":"JD Orcutt","year":"1975","unstructured":"Orcutt JD: Social determinants of alcohol and marijuana effects: a systematic theory. Int J Addict. 1975, 10: 1021-1033.","journal-title":"Int J Addict"},{"key":"190_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/09540260701278929","volume":"19","author":"B Schulze","year":"2007","unstructured":"Schulze B: Stigma and mental health professionals: a review of the evidence on an intricate relationship. Int Rev Psychiatry. 2007, 19: 137-155. 10.1080\/09540260701278929.","journal-title":"Int Rev Psychiatry"},{"key":"190_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0277-9536(02)00028-X","volume":"56","author":"B Schulze","year":"2003","unstructured":"Schulze B, Angermeyer MC: Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Soc Sci Med. 2003, 56: 299-312. 10.1016\/S0277-9536(02)00028-X.","journal-title":"Soc Sci Med"},{"key":"190_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/schbul\/sbn184","volume":"35","author":"C van Zelst","year":"2009","unstructured":"van Zelst C: Stigmatization as an environmental risk in schizophrenia: a user perspective. Schizophrenia bulletin. 2009, 35: 293-296. 10.1093\/schbul\/sbn184.","journal-title":"Schizophrenia bulletin"},{"issue":"Pt 3","key":"190_CR32","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.2044-8260.1992.tb01003.x","volume":"31","author":"A Echebarria Echabe","year":"1992","unstructured":"Echebarria Echabe A, Sanjuan Guillen C, Agustin Ozamiz J: Representations of health, illness and medicines: coping strategies and health-promoting behaviour. Br J Clin Psychol. 1992, 31 (Pt 3): 339-349.","journal-title":"Br J Clin Psychol"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7517-7-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T14:35:00Z","timestamp":1685802900000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/1477-7517-7-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1186\/1477-7517-7-22","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,28]]},"assertion":[{"value":"7 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}